Literature DB >> 25476805

Surgical repair for acute type A aortic dissection in octogenarians.

Ali El-Sayed Ahmad1, Nestoras Papadopoulos1, Faisal Detho1, Edin Srndic1, Petar Risteski1, Anton Moritz1, Andreas Zierer2.   

Abstract

BACKGROUND: Despite limited data, the necessity for immediate surgical intervention in octogenarians with acute type A aortic dissection (AAD) has recently been questioned because the surgical risk may outweigh its potential benefits. At the same time, evolving stent graft technologies are pushing in the market for pathology within the ascending aorta, even for treatment of AAD. Against this background, we analyzed our institutional experience in this patient cohort during the last 8 years.
METHODS: Between October 2005 and October 2013, 39 patients aged older than 80 years (82 ± 2 years) underwent surgical repair for AAD, of which 29 patients (74%) were men. Owing to patient age and comorbidities, we aimed to limit the operation to supracoronary hemiarch replacement whenever possible. Clinical data were prospectively entered into our institutional database. Late follow-up was 3.6 ± 2.8 years and was 100% complete.
RESULTS: Hemiarch replacement was performed in 32 patients (82%), and full arch replacement was necessary in the remaining 7. In 31 patients (79%), the aortic root could be glued and reconstructed or remained untouched. The remaining 8 patients (21%) underwent the bio-Bentall procedure. Mean ventilation time was 46 ± 23 hours, and the intensive care unit stay was 5 ± 9 days. We observed new postoperative permanent neurologic deficits in 2 patients (5%) and transient neurologic deficits in 3 (8%). The 30-day mortality was 26% (n = 10). Kaplan-Meier estimates for late survival were 46% ± 16% at 5 years.
CONCLUSIONS: Given the guidelines regarding the predicted risk of death in patients with untreated AAD, current data suggest a survival benefit with immediate open surgical intervention even in octogenarians. Similarly to the early days of transcatheter-based aortic valve implantation, open surgical reference data are warranted to set the bar for upcoming endovascular treatment of AAD in octogenarians.
Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25476805     DOI: 10.1016/j.athoracsur.2014.08.020

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Emergent aortic surgery in octogenarians: is the advanced age a contraindication?

Authors:  Mario Castaño; Javier Gualis; Jose M Martínez-Comendador; Elio Martín; Pasquale Maiorano; Laura Castillo
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

2.  Ascending aortic replacement for acute type A aortic dissection in octogenarians.

Authors:  Etsuro Suenaga; Manabu Sato; Hideyuki Fumoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-12-16

3.  Hospital mortality of patients aged 80 and older after surgical repair for type A acute aortic dissection in Japan.

Authors:  Tetsu Ohnuma; Daisuke Shinjo; Kiyohide Fushimi
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

4.  Partial upper sternotomy for extensive arch repair in older acute type A aortic dissection patients.

Authors:  Zhihuang Qiu; Jun Xiao; Qingsong Wu; Tianci Chai; Li Zhang; Yumei Li; Liangwan Chen
Journal:  BMC Cardiovasc Disord       Date:  2022-03-21       Impact factor: 2.298

5.  Age, sex, and contemporary outcomes in surgical repair of type A aortic dissection: Insights from the National Inpatient Sample.

Authors:  Michael A Catalano; Tania Mamdouhi; Stevan Pupovac; Kevin F Kennedy; Derek R Brinster; Alan Hartman; Pey-Jen Yu
Journal:  JTCVS Open       Date:  2022-06-23

6.  Outcomes of Acute Aortic Dissection Surgery in Octogenarians.

Authors:  Ming-En Hsu; An-Hsun Chou; Yu-Ting Cheng; Hsiu-An Lee; Kuo-Sheng Liu; Dong-Yi Chen; Victor Chien-Chia Wu; Pao-Hsien Chu; Tien-Hsing Chen; Shao-Wei Chen
Journal:  J Am Heart Assoc       Date:  2020-09-11       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.